Costs and effects in therapy for acute coranary syndromes: The case of abciximab in high- risk patients undergoing percutaneous translumial coranary angioplasty in the EPIC study

BA (Ben) van Hout, L Bowman, DJ Zelinger, Maarten Simoons

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)59-66
Number of pages8
JournalEuropean Heart Journal
Volume19
Publication statusPublished - 1998

Cite this